Early research (Phase 1)Ended earlyNCT03601819
What this trial is testing
Pacritinib in Relapsed/Refractory Lymphoproliferative Disorders
Who this might be right for
Lymphoma, T-Cell, CutaneousLymphoma, T-Cell, PeripheralChronic Lymphocytic Leukemia+4 more
University of Michigan Rogel Cancer Center 4